Renaissance Pharma Ltd

Renaissance Pharma Ltd

featured image of Game-Changing Acquisition: Essential Pharma Takes Over Renaissance Pharma to Revolutionize Pediatric Neuroblastoma Treatment
Companies

Game-Changing Acquisition: Essential Pharma Takes Over Renaissance Pharma to Revolutionize Pediatric Neuroblastoma Treatment

BIOT

📢 Essential Pharma acquires Renaissance Pharma Ltd to commercialize Phase II program Hu14.18K322A, showing promising results in pediatric high-risk neuroblastoma.

Bioprocessupdates

©2023 - 2026 BioprocessUpdates

PRIVACY POLICY terms of service contact